HomeQNCX • NASDAQ
add
Quince Therapeutics Inc
Previous close
$1.00
Day range
$0.97 - $1.04
Year range
$0.51 - $2.45
Market cap
44.88M USD
Avg Volume
142.63K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
MarketWatch
14 hours ago
S&P 500 tallies its first ‘death cross’ in 3 years. Here’s what happens next.
0.79%
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 7.61M | 30.22% |
Net income | -12.46M | -40.07% |
Net profit margin | — | — |
Earnings per share | -0.28 | — |
EBITDA | -7.59M | -37.08% |
Effective tax rate | -0.06% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 40.78M | -45.66% |
Total assets | 114.48M | -31.82% |
Total liabilities | 84.33M | 1.83% |
Total equity | 30.15M | — |
Shares outstanding | 44.00M | — |
Price to book | 1.45 | — |
Return on assets | -15.79% | — |
Return on capital | -36.12% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -12.46M | -40.07% |
Cash from operations | -7.55M | -24.25% |
Cash from investing | 10.87M | 101.61% |
Cash from financing | 0.00 | -100.00% |
Net change in cash | 3.54M | 501.93% |
Free cash flow | -1.27M | -127.64% |
About
Founded
2012
Headquarters
Website
Employees
36
